.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Colorcon
Cerilliant
Accenture
Covington
Federal Trade Commission
Cantor Fitzgerald
Harvard Business School
Daiichi Sankyo
Farmers Insurance

Generated: June 24, 2017

DrugPatentWatch Database Preview

PRANDIN Drug Profile

« Back to Dashboard

Which patents cover Prandin, and when can generic versions of Prandin launch?

Prandin is a drug marketed by Gemini Labs Llc and is included in one NDA.

The generic ingredient in PRANDIN is repaglinide. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the repaglinide profile page.

Summary for Tradename: PRANDIN

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list5
Bulk Api Vendors: see list66
Patent Applications: see list5,341
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PRANDIN at DailyMed

Pharmacology for Tradename: PRANDIN

Drug ClassGlinide
Mechanism of ActionPotassium Channel Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gemini Labs Llc
PRANDIN
repaglinide
TABLET;ORAL020741-001Dec 22, 1997ABRXYesNo► Subscribe► Subscribe
Gemini Labs Llc
PRANDIN
repaglinide
TABLET;ORAL020741-002Dec 22, 1997ABRXYesNo► Subscribe► Subscribe
Gemini Labs Llc
PRANDIN
repaglinide
TABLET;ORAL020741-003Dec 22, 1997ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PRANDIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gemini Labs Llc
PRANDIN
repaglinide
TABLET;ORAL020741-001Dec 22, 19976,143,769► Subscribe
Gemini Labs Llc
PRANDIN
repaglinide
TABLET;ORAL020741-003Dec 22, 19976,143,769► Subscribe
Gemini Labs Llc
PRANDIN
repaglinide
TABLET;ORAL020741-002Dec 22, 19974,873,080► Subscribe
Gemini Labs Llc
PRANDIN
repaglinide
TABLET;ORAL020741-002Dec 22, 19975,216,007► Subscribe
Gemini Labs Llc
PRANDIN
repaglinide
TABLET;ORAL020741-001Dec 22, 19974,873,080► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: PRANDIN

Drugname Dosage Strength RLD Submissiondate
repaglinideTablets0.5 mg, 1 mg and 2 mgPrandin2/10/2005
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
Argus Health
Mallinckrodt
Chinese Patent Office
Fuji
Baxter
Novartis
Cerilliant
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot